3 Reasons Why These 3 Cannabis Stocks Could Have a Magnificent 2026

The cannabis sector is one which many may have rightly described as a bubble seven or eight years ago.

24/7 Wall Street • Jan 27, 2026

MSOS ETF Drops 26% in One Month as Federal Cannabis Policy Stalls

The AdvisorShares Pure US Cannabis ETF has spent the last month on a rollercoaster.

24/7 Wall Street • Jan 18, 2026

How to play cannabis stocks in 2026

President Trump's executive order to reschedule marijuana is one of the many things cannabis investors will be watching in 2026. AdvisorShares portfolio manager Dan Ahrens, who manages the firm's Pure US Cannabis ETF, joins Asking for a Trend to explain where the cannabis industry stands right now.

Yahoo Finance • Jan 18, 2026

Santa Rally Falls Short: Top ETF Performers of December

Santa Rally fizzled as markets stumbled, but ETFs tied to cannabis (MSOS, WEED), metals (SLV, PPLT) and space (UFO) surged.

Zacks Investment Research • Jan 2, 2026

Trump Is Warming to Cannabis, but Investors Aren't Impressed

Stocks took a surprise tumble after the White House moved to reclassify marijuana as a less dangerous drug.

WSJ • Dec 30, 2025

Top & Flop ETF Areas of 2025

Silver, gold & platinum ETFs (SLVP, SILJ, GOEX) crushed it in 2025, while MSOS, MEME & VIXY lagged amid policy, hype & calm markets.

Zacks Investment Research • Dec 30, 2025

Undercovered Dozen: Canadian Natural Resources, Duke Energy, PennyMac Mortgage And More

This week's Undercovered Dozen highlights 12 lesser-followed stocks and funds, each with distinct catalysts or value opportunities. This week's edition covers articles published between Dec. 12 and Dec. 18, offering fresh investment ideas. The series aims to inspire discussion and help investors discover overlooked opportunities in the market.

Seeking Alpha • Dec 22, 2025

Inside the dealmaking that pushed Trump to reclassify pot, expand access

President Donald Trump's marijuana reclassification executive order followed a yearlong push by cannabis executives, billionaire allies and political operatives combining donations, lobbying and targeted polling, according to industry insiders. Trulieve CEO Kim Rivers and Palm Beach billionaire Howard Kessler leveraged personal ties, fundraisers and political spending to press the White House, according to multiple insiders, including one CEO of a cannabis company listed on the New York Stock Exchange, who requested anonymity to speak candidly.

CNBC • Dec 19, 2025

Trump signs executive order to reschedule cannabis. Here's what's next

Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted the President's stance on the drug.

CNBC Television • Dec 19, 2025

Trulieve CEO Kim Rivers reacts to marijuana being reclassified

Trulieve Founder, Chair, and CEO Kim Rivers joins 'Fast Money' with reaction to Pres. Trump reclassifying marijuana.

CNBC Television • Dec 18, 2025